4/A: DSS Amends Filing on $500K Convertible Note to Alset Inc.

DSS, Inc. filed an amended Form 4 to clarify details regarding a $500,000 convertible promissory note issued to Alset Inc., an entity controlled by Director Chan Heng Fai Ambrose.

Summary

• An amended Form 4 was filed by Chan Heng Fai Ambrose and Alset Inc. to clarify information from an original filing on August 22, 2025.
• On August 20, 2025, DSS, Inc. issued a $500,000 convertible promissory note (the "Convertible Promissory Note") to Alset Inc.
• The note allows Alset Inc. to convert outstanding principal and interest into DSS common stock at a conversion price of $0.86 per share.
• Alternatively, if DSS issues any other convertible instruments on terms that differ from the Convertible Promissory Note, Alset Inc. may elect to exchange its note for such new convertible instrument based on the note's principal balance plus any accrued but unpaid interest.
• Mr. Chan's beneficial ownership as of August 22, 2025, includes 1,002,978 shares held by Heng Fai Holdings Limited, 1,184,475 shares held directly, 2,581,268 shares held by Alset Inc., 1,068,309 shares held by Alset International Limited, and 311,634 shares held by Global Biomedical Pte. Ltd., in addition to the $500,000 convertible promissory note held by Alset Inc.

Sentiment

Score: 6

Explanation: The issuance of a convertible note provides capital to the company, which is generally positive. However, the potential for future dilution and the specific conversion terms, including the 'most favored nation' clause, introduce some caution. The amendment itself is a clarification, not a new event.

Positives

• Alset Inc., an entity controlled by Director Chan Heng Fai Ambrose, provided $500,000 in financing to DSS, Inc. through a convertible promissory note, indicating continued insider support.
• The convertible note includes a protective clause allowing Alset Inc. to exchange it for any future convertible instruments issued by DSS on more favorable terms, providing anti-dilution or 'most favored nation' protection for the lender.

Negatives

• The issuance of a convertible promissory note could lead to future dilution for existing shareholders if converted into common stock.
• The conversion price of $0.86 per share provides a benchmark for the valuation of the equity component of the financing, which may be below current market price or represent a discount.

Risks

• Potential dilution of existing shareholders' equity if the convertible promissory note is converted into common stock.
• The 'most favored nation' clause could obligate DSS to offer Alset Inc. more favorable terms if future financing rounds involve different convertible instruments, potentially limiting future financing flexibility or increasing costs.

Future Outlook

The convertible promissory note has an expiration date of July 31, 2028, indicating a medium-term financing arrangement that could lead to equity conversion in the future.

Industry Context

This filing reflects an insider financing event, where a significant shareholder and director provides capital to the company. Such transactions are common in smaller or developing companies seeking capital from existing, committed investors, often at terms that reflect the insider's deep understanding of the company's prospects and risks.

Related Party Transactions

• DSS, Inc. issued a $500,000 convertible promissory note to Alset Inc.
• Alset Inc. is a 10% owner of DSS, Inc. and is controlled by Chan Heng Fai Ambrose, who is also a Director and 10% owner of DSS, Inc. This constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Potential for future dilution if the convertible note is exercised, but also benefits from the company receiving capital.
• Creditors: The convertible note adds to the company's debt, though it has an equity conversion feature.

Next Steps

• Alset Inc. may elect to convert the promissory note into common stock at $0.86 per share or exchange it for other convertible instruments if more favorable terms are offered by DSS.
• The convertible promissory note will mature or expire by July 31, 2028, if not converted earlier.

Key Dates

Recommendation

This filing is an amendment to a beneficial ownership statement, clarifying details of a convertible note issued to a significant insider. While the capital infusion is positive, the potential for future dilution and the protective clauses for the insider warrant a 'hold' stance. The filing does not provide new operational or financial performance data to justify a stronger recommendation.

Keywords

DSS Inc., Form 4/A, Convertible Promissory Note, Alset Inc., Chan Heng Fai Ambrose, Beneficial Ownership, Insider Transaction, Equity Financing, Dilution, SEC Filing